Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: Japan Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20071
20081
20095
20105
20118
20122
20131
20144
20154
20163
20192
20211
20222
20233
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting5
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline17
AstraZeneca12
Boehringer Ingelheim6
Novartis Pharmaceuticals6
Pearl Therapeutics, Inc.4
Sanofi4
Hoffmann-La Roche2
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive52
Bronchitis, Chronic2
Emphysema2
Lung Diseases2
Bronchial Diseases1
Cardiovascular Diseases1
Lung Diseases, Obstructive1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.